Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-009904

Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PISKEL KYLE Chief Financial Officer 2025-05-16 Sale −1,929 $8.89 $17,149 269,581 D: show line 1 in the form
Open-market sales · 1,929 sh · avg $8.89 · $17,149
Loading xslF345X05/form4a.xml…